Picture of Agilent Technologies logo

A Agilent Technologies Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Annual cashflow statement for Agilent Technologies, fiscal year end - October 31st, USD millions except per share, conversion factor applied.

2020
October 31st
2021
October 31st
2022
October 31st
2023
October 31st
2024
October 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line7191,2101,2541,2401,289
Depreciation
Deferred Taxes
Non-Cash Items19042211433186
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital-325-102-478-11683
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Net Change in Other Assets & Liabilities
Cash from Operating Activities9211,4851,3121,7721,751
Capital Expenditures-119-189-291-298-378
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-28-560-47-12-880
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-147-749-338-310-1,258
Financing Cash Flow Items-41-83-67-122-39
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-717-696-1,372-930-752
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash5943-434537-261